Nancy Hessol, MSPH

Photo of Nancy Hessol, MSPH

Email Nancy
(415) 476-3848

3333 California Street
San Francisco, CA 94118

Visit CTSI Profile

  • Professor, School of Pharmacy
  • Associate Director, UCSF-Gladstone CFAR


Nancy Hessol is an epidemiologist whose research interests include HIV disease progression and mortality, HIV-related malignancies, and human Papillomavirus infection. She has more than 30 years of experience directing epidemiologic studies of HIV/AIDS and of health disparities. Professor Hessol has extensive experience working on multisite research projects, analyzing complex databases, and has authored numerous publications. She is considered an international expert on HIV disease progression, with a special emphasis on HIV-related malignancies. From 2001 to 2014 and from 2016 to the present, Professor Hessol has Chaired the NIH sponsored Women’s Interagency HIV Study Cancer & Pathology Working Group. She also has a strong interest in salary equity and is the statistical analyst for the UCSF School of Medicine and School of Pharmacy Faculty Salary Equity Review (FSER), which examines equity among females and under-represented minorities. In 2016, she was selected as the School of Pharmacy senior faculty Equity Advisory to help ensure excellence, equity, and diversity for all recruited faculty at UCSF.

Nancy Hessol received a Master’s of Science in Public Health in epidemiology from UCLA’s School of Public Health in 1982 and following graduation worked on occupational, environmental, and reproductive epidemiological studies at the Hanford Nuclear facilities in Richland, Washington. In 1986 and with a strong desire to work with the growing AIDS epidemic, Ms. Hessol joined the San Francisco Department of Public Health where her research focused on HIV disease progression. Seven years later, she began employment at UCSF where she is currently a Professor in the Departments of Clinical Pharmacy and of Medicine. In 2003, she received a UCSF Champion of Diversity award for her research activities in health disparities. In March 2010, she received the Lifetime Achievement Award from the UCLA School of Public Health and was inducted into the UCLA School of Public Health Hall of Fame. She is a ten-time winner of the Apple for Teachers Award given by the Dean of the UCSF School of Pharmacy.

Nancy Hessol has been the course director for the School of Pharmacy Research Seminar, Study Design and Evaluation, and co-director for Foundations I. She also serves on the School of Pharmacy Curriculum Transformation Committee, the Admissions Committee, and Student Progress Committee. She is also an active member on the Academic Senate Committee for Equal Opportunity.

Displaying 1 - 158 of 158

  1. Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Achenbach CJ, Hessol NA, D'Souza G, Gebo KA, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Park LS, Rabkin CS, Salters K, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. Lancet HIV. 2019 Feb 27. View on Pubmed
  2. Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Anastos K, Xie X, Minkoff H, Xue X, Reimers LL, Kuniholm M, D'Souza G, Colie C, Aouizerat B, Palefsky JM, Strickler HD. Racial differences in human papilloma virus types amongst United States women with HIV and cervical precancer. AIDS. 2018 Nov 28; 32(18):2821-2826. View on Pubmed
  3. Cook JA, Burke-Miller JK, Steigman PJ, Schwartz RM, Hessol NA, Milam J, Merenstein DJ, Anastos K, Golub ET, Cohen MH. Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV. AIDS Behav. 2018 Oct; 22(10):3141-3154. View on Pubmed
  4. Hessol NA, Whittemore H, Vittinghoff E, Hsu LC, Ma D, Scheer S, Schwarcz SK. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study. Lancet HIV. 2018 Nov; 5(11):e647-e655. View on Pubmed
  5. Gradissimo A, Lam J, Attonito JD, Palefsky J, Massad LS, Xie X, Eltoum IE, Rahangdale L, Fischl MA, Anastos K, Minkoff H, Xue X, D'Souza G, Flowers LC, Colie C, Shrestha S, Hessol NA, Strickler HD, Burk RD. Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women. Cancer Epidemiol Biomarkers Prev. 2018 Dec; 27(12):1407-1415. View on Pubmed
  6. Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R. Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr. 2018 Aug 15; 78(5):499-504. View on Pubmed
  7. Greene M, Hessol NA, Perissinotto C, Zepf R, Hutton Parrott A, Foreman C, Whirry R, Gandhi M, John M. Loneliness in Older Adults Living with HIV. AIDS Behav. 2018 May; 22(5):1475-1484. View on Pubmed
  8. Scheer S, Hsu L, Schwarcz S, Pipkin S, Havlir D, Buchbinder S, Hessol NA. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era. Clin Infect Dis. 2018 Mar 19; 66(7):1027-1034. View on Pubmed
  9. Hessol NA, Zepf R, Zobell E, Weiser SD, John MD. Food Insecurity and Aging Outcomes in Older Adults Living with HIV. AIDS Behav. 2017 Dec; 21(12):3506-3514. View on Pubmed
  10. Hessol NA, Ma D, Scheer S, Hsu LC, Schwarcz SK. Changing temporal trends in non-AIDS cancer mortality among people diagnosed with AIDS: San Francisco, California, 1996-2013. Cancer Epidemiol. 2018 02; 52:20-27. View on Pubmed
  11. Hessol NA, Strickler HD. Cancer risk in people living with HIV. Lancet HIV. 2017 11; 4(11):e477-e479. View on Pubmed
  12. Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, D'Souza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390. View on Pubmed
  13. Hessol NA, Schwarcz SK, Hsu LC, Shumway M, Machtinger EL. Gender differences in causes of death among persons with HIV/AIDS in San Francisco, California, 1996-2013. Int J STD AIDS. 2018 02; 29(2):135-146. View on Pubmed
  14. Massad LS, Hessol NA, Darragh TM, Minkoff H, Colie C, Wright RL, Cohen M, Seaberg EC. Cervical cancer incidence after up to 20 years of observation among women with HIV. Int J Cancer. 2017 10 15; 141(8):1561-1565. View on Pubmed
  15. Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis. 2017 02 15; 64(4):468-475. View on Pubmed
  16. Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC. Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. AIDS Patient Care STDS. 2016 10; 30(10):445-454. View on Pubmed
  17. John MD, Greene M, Hessol NA, Zepf R, Parrott AH, Foreman C, Bourgeois J, Gandhi M, Hare CB. Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco. J Acquir Immune Defic Syndr. 2016 08 15; 72(5):534-41. View on Pubmed
  18. Scott HM, Irvin R, Wilton L, Van Tieu H, Watson C, Magnus M, Chen I, Gaydos C, Hussen SA, Mannheimer S, Mayer K, Hessol NA, Buchbinder S. Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United States. PLoS One. 2015; 10(12):e0146025. View on Pubmed
  19. Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med. 2015 Oct 06; 163(7):507-18. View on Pubmed
  20. Siewe B, Pham JT, Cohen M, Hessol NA, Levine A, Martinez-Maza O, Landay A. Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. AIDS. 2015 Aug 24; 29(13):1659-64. View on Pubmed
  21. Hessol NA, Holman S, Minkoff H, Cohen MH, Golub ET, Kassaye S, Karim R, Sosanya O, Shaheen C, Merhi Z. Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV. AIDS Care. 2016; 28(1):11-21. View on Pubmed
  22. Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, Anastos K, Xie X, Minkoff H, Xue X, D'Souza G, Flowers L, Levine AM, Colie C, Rahangdale L, Fischl MA, Palefsky JM, Strickler HD. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Clin Infect Dis. 2015 Nov 15; 61(10):1573-81. View on Pubmed
  23. Hessol NA, Martínez-Maza O, Levine AM, Morris A, Margolick JB, Cohen MH, Jacobson LP, Seaberg EC. Lung cancer incidence and survival among HIV-infected and uninfected women and men. AIDS. 2015 Jun 19; 29(10):1183-93. View on Pubmed
  24. Volk JE, Lippman SA, Grinsztejn B, Lama JR, Fernandes NM, Gonzales P, Hessol NA, Buchbinder S. Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil. Int J STD AIDS. 2016 06; 27(7):531-6. View on Pubmed
  25. Massad LS, Evans CT, Weber KM, D'Souza G, Hessol NA, Wright RL, Colie C, Strickler HD, Wilson TE. Changes in knowledge of cervical cancer following introduction of human papillomavirus vaccine among women at high risk for cervical cancer. Gynecol Oncol Rep. 2015 Apr 01; 12:37-40. View on Pubmed
  26. Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015 Jun; 119(6):802-13. View on Pubmed
  27. Goedert JJ, Swenson LC, Napolitano LA, Haddad M, Anastos K, Minkoff H, Young M, Levine A, Adeyemi O, Seaberg EC, Aouizerat B, Rabkin CS, Harrigan PR, Hessol NA. Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencing. J Acquir Immune Defic Syndr. 2015 Jan 01; 68(1):30-5. View on Pubmed
  28. Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, Irvin R, Sineath RC, Sanchez T, Sullivan PS, Buchbinder SP. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS. 2014 Dec; 28(12):622-7. View on Pubmed
  29. Schwarcz SK, Vu A, Hsu LC, Hessol NA. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS Patient Care STDS. 2014 Oct; 28(10):517-23. View on Pubmed
  30. Fuentes-Afflick E, Odouli R, Escobar GJ, Stewart AL, Hessol NA. Maternal acculturation and the prenatal care experience. J Womens Health (Larchmt). 2014 Aug; 23(8):688-706. View on Pubmed
  31. Hessol NA, Fuentes-Afflick E. The impact of migration on pregnancy outcomes among Mexican-origin women. J Immigr Minor Health. 2014 Jun; 16(3):377-84. View on Pubmed
  32. Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen MH. Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. Am J Prev Med. 2014 Jul; 47(1):53-69. View on Pubmed
  33. Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):587-96. View on Pubmed
  34. Uldrick TS, Pipkin S, Scheer S, Hessol NA. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS. 2014 Jan 28; 28(3):397-405. View on Pubmed
  35. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952. View on Pubmed
  36. Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG. The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Int J STD AIDS. 2014 Apr; 25(5):332-40. View on Pubmed
  37. Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, D'Souza G, Gustafson DR, Silver S, Martínez-Maza O. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2084-93. View on Pubmed
  38. Hessol NA, Holly EA, Efird JT, Minkoff H, Weber KM, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS. 2013 Jul 17; 27(11):1743-51. View on Pubmed
  39. Mirmirani P, Maurer T, Cohen M, D'Souza G, Karim R, Plankey M, Robison E, Sharma A, Tien PC, Hessol NA. Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy. Int J Dermatol. 2014 Oct; 53(10):e443-8. View on Pubmed
  40. Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, Hessol NA, Wilson TE, Plankey M, Howard AA, Sharp GB, Richardson JL, Cohen MH. Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav. 2013 Jun; 17(5):1705-12. View on Pubmed
  41. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, Strickler HD. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013 Apr 01; 62(4):405-13. View on Pubmed
  42. Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR, Alden CB, Detels R, Greenblatt RM, Hessol NA, Holman S, Huang L, Kleerup EC, Phair J, Sutton SH, Seaberg EC, Margolick JB, Wisniewski SR, Morris A. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One. 2013; 8(3):e58812. View on Pubmed
  43. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82. View on Pubmed
  44. Hessol NA, Ameli N, Cohen MH, Urwin S, Weber KM, Tien PC. The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2013 Jan 01; 62(1):74-80. View on Pubmed
  45. Massad LS, D'Souza G, Tian F, Minkoff H, Cohen M, Wright RL, Colie C, Hessol NA. Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus. Obstet Gynecol. 2012 Oct; 120(4):791-7. View on Pubmed
  46. Hessol NA, Odouli R, Escobar GJ, Stewart AL, Fuentes-Afflick E. Interpersonal processes of care and cesarean delivery in two health care settings. Am J Public Health. 2012 Sep; 102(9):1722-8. View on Pubmed
  47. Massad LS, Weber KM, Wilson TE, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Levine AM, Watts DH, Evans CT. Correlating knowledge of cervical cancer prevention and human papillomavirus with compliance after colposcopy referral. J Low Genit Tract Dis. 2012 Apr; 16(2):98-105. View on Pubmed
  48. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34. View on Pubmed
  49. Varnum SM, Webb-Robertson BJ, Hessol NA, Smith RD, Zangar RC. Plasma biomarkers for detecting Hodgkin's lymphoma in HIV patients. PLoS One. 2011; 6(12):e29263. View on Pubmed
  50. Schwartz RM, Mansoor A, Wilson TE, Anastos K, Everson-Rose SA, Golub ET, Goparaju L, Hessol NA, Mack WJ, Lazar J. Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women. AIDS Care. 2012; 24(3):394-403. View on Pubmed
  51. Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. J Acquir Immune Defic Syndr. 2011 Mar 01; 56(3):253-62. View on Pubmed
  52. Pipkin S, Scheer S, Okeigwe I, Schwarcz S, Harris DH, Hessol NA. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry. AIDS. 2011 Feb 20; 25(4):463-71. View on Pubmed
  53. Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D'Souza G, Greenblatt RM, Goedert JJ. HIV tropism and decreased risk of breast cancer. PLoS One. 2010 Dec 16; 5(12):e14349. View on Pubmed
  54. Massad LS, Evans CT, Weber KM, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Watts DH, Wilson TE. Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. Obstet Gynecol. 2010 Oct; 116(4):941-7. View on Pubmed
  55. Jones AS, Lillie-Blanton M, Stone VE, Ip EH, Zhang Q, Wilson TE, Cohen MH, Golub ET, Hessol NA. Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women. Womens Health Issues. 2010 Sep; 20(5):335-42. View on Pubmed
  56. Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watts DH. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol. 2010 Mar 20; 28(9):1514-9. View on Pubmed
  57. Massad LS, Evans CT, Wilson TE, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Levine AM, Watts DH, Weber KM. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol. 2010 Apr; 117(1):70-6. View on Pubmed
  58. Goldberg D, Weber KM, Orsi J, Hessol NA, D'Souza G, Watts DH, Schwartz R, Liu C, Glesby M, Burian P, Cohen MH. Smoking cessation among women with and at risk for HIV: are they quitting? J Gen Intern Med. 2010 Jan; 25(1):39-44. View on Pubmed
  59. Lillie-Blanton M, Stone VE, Snow Jones A, Levi J, Golub ET, Cohen MH, Hessol NA, Wilson TE. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health. 2010 Aug; 100(8):1493-9. View on Pubmed
  60. Hessol NA, Weber KM, Holman S, Robison E, Goparaju L, Alden CB, Kono N, Watts DH, Ameli N. Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. J Womens Health (Larchmt). 2009 Oct; 18(10):1627-37. View on Pubmed
  61. Fuentes-Afflick E, Hessol NA. Immigration status and use of health services among Latina women in the San Francisco Bay Area. J Womens Health (Larchmt). 2009 Aug; 18(8):1275-80. View on Pubmed
  62. French AL, Gawel SH, Hershow R, Benning L, Hessol NA, Levine AM, Anastos K, Augenbraun M, Cohen MH. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):399-406. View on Pubmed
  63. Cook RL, Zhu F, Belnap BH, Weber K, Cook JA, Vlahov D, Wilson TE, Hessol NA, Plankey M, Howard AA, Cole SR, Sharp GB, Richardson JL, Cohen MH. Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol. 2009 Apr 15; 169(8):1025-32. View on Pubmed
  64. Massad LS, Seaberg EC, Watts DH, Minkoff H, Levine AM, Henry D, Colie C, Darragh TM, Hessol NA. Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer. 2009 Feb 01; 115(3):524-30. View on Pubmed
  65. Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS. 2009 Jan 02; 23(1):59-70. View on Pubmed
  66. Wojcicki JM, Hessol NA, Heyman MB, Fuentes-Afflick E. Risk factors for macrosomia in infants born to Latina women. J Perinatol. 2008 Nov; 28(11):743-9. View on Pubmed
  67. Dolev JC, Maurer T, Springer G, Glesby MJ, Minkoff H, Connell C, Young M, Schowalter K, Cox C, Hessol NA. Incidence and risk factors for verrucae in women. AIDS. 2008 Jun 19; 22(10):1213-9. View on Pubmed
  68. Fuentes-Afflick E, Hessol NA. Overweight in young Latino children. Arch Med Res. 2008 Jul; 39(5):511-8. View on Pubmed
  69. Fuentes-Afflick E, Hessol NA. Acculturation and Body Mass among Latina Women. J Womens Health (Larchmt). 2008 Jan-Feb; 17(1):67-73. View on Pubmed
  70. Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, Cole S, Vigen C, Cohen M, Young M, Justman J. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr. 2007 May 01; 45(1):34-42. View on Pubmed
  71. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007 May 15; 165(10):1143-53. View on Pubmed
  72. López-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, Preston-Martin S, Anastos K. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol. 2007 May 15; 165(10):1134-42. View on Pubmed
  73. Anastos K, Lu D, Shi O, Mulligan K, Tien PC, Freeman R, Cohen MH, Justman J, Hessol NA. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther. 2007; 12(7):1049-58. View on Pubmed
  74. Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R, Cohen MH. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis. 2007 Jan 15; 44(2):287-94. View on Pubmed
  75. Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer. 2006 Sep 04; 95(5):642-8. View on Pubmed
  76. Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richardson JL, Williams P, Gange SJ. Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. Am J Public Health. 2006 Jun; 96(6):1044-51. View on Pubmed
  77. Ameli N, Bacchetti P, Morrow RA, Hessol NA, Wilkin T, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS. 2006 Apr 24; 20(7):1051-8. View on Pubmed
  78. Fuentes-Afflick E, Hessol NA, Bauer T, O'Sullivan MJ, Gomez-Lobo V, Holman S, Wilson TE, Minkoff H. Use of prenatal care by Hispanic women after welfare reform. Obstet Gynecol. 2006 Jan; 107(1):151-60. View on Pubmed
  79. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005 Sep; 12(9):1013-9. View on Pubmed
  80. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E, Lu D, Williams T, Wichienkuer P, Anastos K. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. J Acquir Immune Defic Syndr. 2005 May 01; 39(1):55-62. View on Pubmed
  81. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS. 2005 Mar 04; 19(4):357-70. View on Pubmed
  82. Hessol NA, Fuentes-Afflick E. Ethnic differences in neonatal and postneonatal mortality. Pediatrics. 2005 Jan; 115(1):e44-51. View on Pubmed
  83. Mulligan K, Anastos K, Justman J, Freeman R, Wichienkuer P, Robison E, Hessol NA. Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):18-22. View on Pubmed
  84. Tien PC, Kovacs A, Bacchetti P, French AL, Augenbraun M, Cole SR, Hessol N, Justman J. Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Nov 01; 39(9):1363-70. View on Pubmed
  85. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2004 Aug 01; 36(4):978-85. View on Pubmed
  86. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, Wilson TE, Young MA, Hessol NA. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004 Jul; 94(7):1133-40. View on Pubmed
  87. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004 May; 190(5):1241-8. View on Pubmed
  88. Hessol NA, Missett B, Fuentes-Afflick E. Lower agreement on behavioral factors than on medical conditions in self-reported data among pregnant Latina women. Arch Med Res. 2004 May-Jun; 35(3):241-5. View on Pubmed
  89. Hessol NA, Vittinghoff E, Fuentes-Afflick E. Reduced risk of inadequate prenatal care in the era after Medicaid expansions in California. Med Care. 2004 May; 42(5):416-22. View on Pubmed
  90. Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis. 2004 Feb 15; 38(4):579-84. View on Pubmed
  91. Massad LS, Seaberg EC, Watts DH, Hessol NA, Melnick S, Bitterman P, Anastos K, Silver S, Levine AM, Minkoff H. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS. 2004 Jan 02; 18(1):109-13. View on Pubmed
  92. Mirmirani P, Hessol NA, Maurer TA, Berger TG, Greenblatt RM, Price VH. Hair changes in women from the Women's Interagency HIV Study. Arch Dermatol. 2003 Jan; 139(1):105-6. View on Pubmed
  93. Anastos K, Barrón Y, Miotti P, Weiser B, Young M, Hessol N, Greenblatt RM, Cohen M, Augenbraun M, Levine A, Muñoz A. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med. 2002 Sep 23; 162(17):1973-80. View on Pubmed
  94. Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Minkoff H, Hessol NA. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002 Aug 01; 113(2):91-8. View on Pubmed
  95. Preston-Martin S, Kirstein LM, Pogoda JM, Rimer B, Melnick S, Masri-Lavine L, Silver S, Hessol N, French AL, Feldman J, Sacks HS, Deely M, Levine AM. Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). Prev Med. 2002 Mar; 34(3):386-92. View on Pubmed
  96. Hessol NA, Schneider M, Greenblatt RM, Bacon M, Barranday Y, Holman S, Robison E, Williams C, Cohen M, Weber K. Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol. 2001 Sep 15; 154(6):563-73. View on Pubmed
  97. Vittinghoff E, Hessol NA, Bacchetti P, Fusaro RE, Holmberg SD, Buchbinder SP. Cofactors for HIV disease progression in a cohort of homosexual and bisexual men. J Acquir Immune Defic Syndr. 2001 Jul 01; 27(3):308-14. View on Pubmed
  98. Hessol NA, Schwarcz S, Ameli N, Oliver G, Greenblatt RM. Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol. 2001 Jun 01; 153(11):1128-33. View on Pubmed
  99. Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, Greenblatt RM. Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS). J Am Acad Dermatol. 2001 May; 44(5):785-8. View on Pubmed
  100. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000 Nov 15; 92(22):1823-30. View on Pubmed
  101. Hessol NA, Fuentes-Afflick E. The perinatal advantage of Mexican-origin Latina women. Ann Epidemiol. 2000 Nov; 10(8):516-23. View on Pubmed
  102. Hessol NA, Anastos K, Levine AM, Ameli N, Cohen M, Young M, Augenbraun M, Miotti P, Gange SJ. Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group. AIDS Res Hum Retroviruses. 2000 Aug 10; 16(12):1105-11. View on Pubmed
  103. Fuentes-Afflick E, Hessol NA. Interpregnancy interval and the risk of premature infants. Obstet Gynecol. 2000 Mar; 95(3):383-90. View on Pubmed
  104. Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, Delapenha R, DeHovitz J, Cohen M, Meyer W, Bremer J, Kovacs A. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS. 1999 Sep 10; 13(13):1717-26. View on Pubmed
  105. Palacio H, Shiboski CH, Yelin EH, Hessol NA, Greenblatt RM. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr. 1999 Aug 01; 21(4):293-300. View on Pubmed
  106. Fuentes-Afflick E, Hessol NA, Pérez-Stable EJ. Testing the epidemiologic paradox of low birth weight in Latinos. Arch Pediatr Adolesc Med. 1999 Feb; 153(2):147-53. View on Pubmed
  107. Fuentes-Afflick E, Hessol NA, Pérez-Stable EJ. Maternal birthplace, ethnicity, and low birth weight in California. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1105-12. View on Pubmed
  108. Hessol NA, Fuentes-Afflick E, Bacchetti P. Risk of low birth weight infants among black and white parents. Obstet Gynecol. 1998 Nov; 92(5):814-22. View on Pubmed
  109. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, Schachter J. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol. 1998 May; 178(5):987-90. View on Pubmed
  110. Korn AP, Grullon K, Hessol N, Lin P, Siopak J. Does vaginal cuff closure decrease the infectious morbidity associated with abdominal hysterectomy? J Am Coll Surg. 1997 Oct; 185(4):404-7. View on Pubmed
  111. Ellen JM, Hessol NA, Kohn RP, Bolan GA. An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989-1993: evidence for core groups. J Infect Dis. 1997 Jun; 175(6):1519-22. View on Pubmed
  112. Fuentes-Afflick E, Hessol NA. Impact of Asian ethnicity and national origin on infant birth weight. Am J Epidemiol. 1997 Jan 15; 145(2):148-55. View on Pubmed
  113. Koblin BA, Hessol NA, Zauber AG, Taylor PE, Buchbinder SP, Katz MH, Stevens CE. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996 Nov 15; 144(10):916-23. View on Pubmed
  114. Hessol NA, Priddy FH, Bolan G, Baumrind N, Vittinghoff E, Reingold AL, Padian NS. Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis. 1996 Mar-Apr; 23(2):157-63. View on Pubmed
  115. Hessol NA, Palacio H. Gender, ethnicity and transmission category variation in HIV disease progression. AIDS. 1996; 10 Suppl A:S69-74. View on Pubmed
  116. Korn AP, Hessol N, Padian N, Bolan G, Muzsnai D, Donegan E, Jonte J, Schachter J, Landers DV. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis. 1995 Nov-Dec; 22(6):335-41. View on Pubmed
  117. Katz MH, Chang SW, Buchbinder SP, Hessol NA, O'Malley P, Doll LS. Health insurance and use of medical services by men infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 01; 8(1):58-63. View on Pubmed
  118. Buchbinder SP, Katz MH, Hessol NA, Liu J, O'Malley PM, Alter MJ. Hepatitis C virus infection in sexually active homosexual men. J Infect. 1994 Nov; 29(3):263-9. View on Pubmed
  119. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994 Aug; 8(8):1123-8. View on Pubmed
  120. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis. 1994 Jul; 170(1):198-202. View on Pubmed
  121. Hessol NA, Koblin BA, van Griensven GJ, Bacchetti P, Liu JY, Stevens CE, Coutinho RA, Buchbinder SP, Katz MH. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol. 1994 Jun 01; 139(11):1077-87. View on Pubmed
  122. Lifson AR, Hilton JF, Westenhouse JL, Canchola AJ, Samuel MC, Katz MH, Buchbinder SP, Hessol NA, Osmond DH, Shiboski S. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS. 1994 Jan; 8(1):73-9. View on Pubmed
  123. van Griensven GJ, Hessol NA, Koblin BA, Byers RH, O'Malley PM, Albercht-van Lent N, Buchbinder SP, Taylor PE, Stevens CE, Coutinho RA. Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. Am J Epidemiol. 1993 Apr 15; 137(8):909-15. View on Pubmed
  124. Bacchetti P, Segal MR, Hessol NA, Jewell NP. Different AIDS incubation periods and their impacts on reconstructing human immunodeficiency virus epidemics and projecting AIDS incidence. Proc Natl Acad Sci U S A. 1993 Mar 15; 90(6):2194-6. View on Pubmed
  125. Samuel MC, Hessol N, Shiboski S, Engel RR, Speed TP, Winkelstein W. Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984-1989. J Acquir Immune Defic Syndr. 1993 Mar; 6(3):303-12. View on Pubmed
  126. Katz MH, Hessol NA, Buchbinder SP, Mebane WR, O'Malley P, Lemp GF, Holmberg SD. Use of Bayes theorem to estimate the impact of the proposed CD4-based expansion of the AIDS case definition. J Acquir Immune Defic Syndr. 1993 Mar; 6(3):295-7. View on Pubmed
  127. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992 Nov; 166(5):1153-6. View on Pubmed
  128. Winkler JR, Herrera C, Westenhouse J, Robinson P, Hessol N, Buchbinder S, Greenspan JS, Katz MH. Periodontal disease in HIV-infected and uninfected homosexual and bisexual men. AIDS. 1992 Sep; 6(9):1041-3. View on Pubmed
  129. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med. 1992 Aug 15; 117(4):309-11. View on Pubmed
  130. Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet. 1992 Jun 13; 339(8807):1436-40. View on Pubmed
  131. Longini IM, Byers RH, Hessol NA, Tan WY. Estimating the stage-specific numbers of HIV infection using a Markov model and back-calculation. Stat Med. 1992 Apr; 11(6):831-43. View on Pubmed
  132. Hessol NA, Buchbinder SP, Colbert D, Scheer S, Underwood R, Barnhart JL, O'Malley PM, Doll LS, Lifson AR. Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates. Am J Public Health. 1992 Apr; 82(4):561-4. View on Pubmed
  133. Lifson AR, Hessol NA, Rutherford GW. Progression and clinical outcome of infection due to human immunodeficiency virus. Clin Infect Dis. 1992 Apr; 14(4):966-72. View on Pubmed
  134. Hessol NA, Buchbinder SP. Predictors of HIV disease progression in the era of prophylactic therapies. AIDS Clin Rev. 1992; 25-40. View on Pubmed
  135. Katz MH, Greenspan D, Westenhouse J, Hessol NA, Buchbinder SP, Lifson AR, Shiboski S, Osmond D, Moss A, Samuel M. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS. 1992 Jan; 6(1):95-100. View on Pubmed
  136. Lifson AR, Hessol NA, Buchbinder SP, Holmberg SD. The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. AIDS. 1991 Oct; 5(10):1209-15. View on Pubmed
  137. Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, Holmberg SD. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis. 1991 May; 163(5):959-65. View on Pubmed
  138. Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W, Lang W, Samuel M, Buchbinder SP, Hessol NA, Lifson AR. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS. 1991 May; 5(5):519-25. View on Pubmed
  139. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health. 1990 Dec; 80(12):1509-11. View on Pubmed
  140. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990 Nov 24; 301(6762):1183-8. View on Pubmed
  141. Lemp GF, Payne SF, Rutherford GW, Hessol NA, Winkelstein W, Wiley JA, Moss AR, Chaisson RE, Chen RT, Feigal DW. Projections of AIDS morbidity and mortality in San Francisco. JAMA. 1990 Mar 16; 263(11):1497-501. View on Pubmed
  142. Lifson AR, Darrow WW, Hessol NA, O'Malley PM, Barnhart JL, Jaffe HW, Rutherford GW. Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors. Am J Epidemiol. 1990 Feb; 131(2):221-31. View on Pubmed
  143. Doll LS, O'Malley PM, Pershing AL, Darrow WW, Hessol NA, Lifson AR. High-risk sexual behavior and knowledge of HIV antibody status in the San Francisco City Clinic Cohort. Health Psychol. 1990; 9(3):253-65. View on Pubmed
  144. Lifson AR, Darrow WW, Hessol NA, O'Malley PM, Barnhart L, Jaffe HW, Rutherford GW. Kaposi's sarcoma among homosexual and bisexual men enrolled in the San Francisco City Clinic Cohort Study. J Acquir Immune Defic Syndr. 1990; 3 Suppl 1:S32-7. View on Pubmed
  145. Hessol NA, Lifson AR. Predictors of HIV disease progression. AIDS Clin Rev. 1990; 63-79. View on Pubmed
  146. Hessol NA, Byers RH, Lifson AR, O'Malley PM, Cannon L, Barnhart JL, Harrison JS, Rutherford GW. Relationship between AIDS latency period and AIDS survival time in homosexual and bisexual men. J Acquir Immune Defic Syndr. 1990; 3(11):1078-85. View on Pubmed
  147. Hessol NA, Lifson AR, O'Malley PM, Doll LS, Jaffe HW, Rutherford GW. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol. 1989 Dec; 130(6):1167-75. View on Pubmed
  148. Janssen RS, Saykin AJ, Cannon L, Campbell J, Pinsky PF, Hessol NA, O'Malley PM, Lifson AR, Doll LS, Rutherford GW. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection. Ann Neurol. 1989 Nov; 26(5):592-600. View on Pubmed
  149. Jason J, Lui KJ, Ragni MV, Hessol NA, Darrow WW. Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA. 1989 Feb 03; 261(5):725-7. View on Pubmed
  150. Hessol NA, Lifson AR, Rutherford GW. Natural history of human immunodeficiency virus infection and key predictors of HIV disease progression. AIDS Clin Rev. 1989; 69-93. View on Pubmed
  151. Omenn GS, Thompson B, Sexton M, Hessol N, Breitenstein B, Curry S, Michnich M, Peterson A. A randomized comparison of Worksite-sponsored smoking cessation programs. Am J Prev Med. 1988 Sep-Oct; 4(5):261-7. View on Pubmed
  152. Byers RH, Morgan WM, Darrow WW, Doll L, Jaffe HW, Rutherford G, Hessol N, O'Malley PM. Estimating AIDS infection rates in the San Francisco cohort. AIDS. 1988 Jun; 2(3):207-10. View on Pubmed
  153. Sever LE, Gilbert ES, Hessol NA, McIntyre JM. A case-control study of congenital malformations and occupational exposure to low-level ionizing radiation. Am J Epidemiol. 1988 Feb; 127(2):226-42. View on Pubmed
  154. Sever LE, Hessol NA, Gilbert ES, McIntyre JM. The prevalence at birth of congenital malformations in communities near the Hanford site. Am J Epidemiol. 1988 Feb; 127(2):243-54. View on Pubmed
  155. Thompson B, Omenn G, Sexton M, Breitenstein B, Hessol N, Curry S, Michnich M, Peterson A. Worksite smoking cessation: a test of two programs. Prog Clin Biol Res. 1987; 248:93-100. View on Pubmed
  156. Hessol NA. Worksite smoking modification competitions: long-term vs short-term success. Am J Public Health. 1986 Jul; 76(7):819-20. View on Pubmed
  157. Kraus JF, Black MA, Hessol N, Ley P, Rokaw W, Sullivan C, Bowers S, Knowlton S, Marshall L. The incidence of acute brain injury and serious impairment in a defined population. Am J Epidemiol. 1984 Feb; 119(2):186-201. View on Pubmed
  158. Sever LE, Hessol NA. Overall design considerations in male and female occupational reproductive studies. Prog Clin Biol Res. 1984; 160:15-47. View on Pubmed